参考文献/References:
[1] 屈直,王芬,李志明,等.二陈汤对Lewis肺癌移植瘤生长及Hedgehog通路蛋白表达的影响[J].陕西中医,2022,43(5):555-558,563.
[2] 李博文,张心宇,刘洋,等.肺腺癌患者血清长链非编码RNA miR155HG表达及意义[J].陕西医学杂志,2022,51(4):492-496.
[3] SONG J,SUN Y,CAO H,et al.A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma[J].Bioengineered,2021,12(1):5932-5949.
[4] 郑茜,刘远婷,丁甜甜,等.消积抑癌外敷方对Lewis肺癌荷瘤小鼠肿瘤生长及Survivin蛋白表达的影响[J].陕西中医,2021,42(9):1175-1178.
[5] 龙焕屏,李光.肺腺癌预后不良的重要基因CDC20、CCNB2和CDC45[J].中国医科大学学报,2021,50(9):846-850.
[6] ROHAN S,TU J J,KAO J,et al.Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes[J].Clin Cancer Res,2006,12(23):6937-6945.
[7] KUDO I,ESUMI M,KUSUMI Y,et al.Particular gene upregulation and p53 heterogeneous expression in TP53-mutated maxillary carcinoma[J].Oncol Lett,2017,14(4):4633-4640.
[8] PING S,WANG S,ZHAO Y,et al.Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma[J].Cancer Med,2022,11(18):3529-3541.
[9] 曾颖靓,厉红元.PROM2通过β-catenin/HER2通路调控乳腺癌细胞SK-BR-3的迁移、侵袭、增殖和凋亡[J].中国生物化学与分子生物学报,2020,36(4):411-420.
[10] NGUYEN T T,GAPIHAN G,TETU P,et al.Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes[J].Clin Transl Med,2020,10(8):e198.
[11] ZHANG B,CHU W,WEN F,et al.Dysregulation of long non-coding RNAs and mRNAs in plasma of clear cell renal cell carcinoma patients using microarray and bioinformatic analysis[J].Front Oncol,2020,10:559730.
[12] 韩乐,陈文娟,张一力.肺腺癌392例临床病理特征与骨转移相关性分析[J].陕西医学杂志,2020,49(12):1688-1690.
[13] LUO W,WANG J,XU W,et al.LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer[J].Cell Death Dis,2021,12(11):1043.
[14] 刘爱东,张爽,王丹琳,等.MMP-19在胃腺癌中的表达及与神经型钙黏素的相关性[J].重庆医科大学学报,2022,47(2):145-150.
[15] 刘爱东,唐慧,刘芳,等.基质金属蛋白酶-21在老年结肠腺癌患者术后组织中的表达及意义[J].国际老年医学杂志,2021,42(6):335-338.
[16] LI W,ZHU Y,ZHANG K,et al.PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer[J].Exp Mol Med,2020,52(3):409-422.
[17] SAHA S K,ISLAM S M R,KWAK K S,et al.PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer:A multiomics analysis[J].Cancer Gene Ther,2020,27(3-4):147-167.
[18] AN J,SHI J,YANG C,et al.Regulation of tumorigenesis and ferroptosis in non-small cell lung cancer by a novel BBOX1-AS1/miR-326/PROM2 axis[J].Mol Cell Biochem,2023,28:1-5.
[19] SINGH R D,SCHROEDER A S,SCHEFFER L,et al.Prominin-2 expression increases protrusions,decreases caveolae and inhibits Cdc42 dependent fluid phase endocytosis[J].Biochem Biophys Res Commun,2013,434(3):466-472.
[20] JIANG J,ZHANG C,WANG J,et al.Knockdown of PROM2 enhances paclitaxel sensitivity in endometrial cancer cells by regulating the AKT/FOXO1 pathway[J].Anticancer Agents Med Chem,202,23(19):2127-2134.
[21] SHI J Y,CHE X,WEN R,et al.Ferroptosis biomarkers predict tumor mutation burden's impact on prognosis in HER2-positive breast cancer[J].World J Clin Oncol,2024,15(3):391-410.
[22] 郭桓博,马瑞雪,朱正望,等.中药基于铁死亡机制防治肝癌研究进展[J].陕西中医,2024,45(2):282-285.
[23] BROWN C W,CHHOY P,MUKHOPADHYAY D,et al.Targeting prominin2 transcription to overcome ferroptosis resistance in cancer[J].EMBO Mol Med,2021,13(8):e13792.
[24] PARIS J,WILHELM C,LEBBE C,et al.PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers[J].Clin Transl Med,2024,14(3):e1632.
[25] XU Y,FAN P,XU X,et al.Tert-butyl hydroperoxide induces ferroptosis of bone mesenchymal stem cells by repressing the prominin2/BACH1/ROS axis[J].Am J Physiol Cell Physiol,2023,325(5):c1212-c1227.
相似文献/References:
[1]邵景韫,刘安,杜旭升,等.尿激酶对大鼠肺成纤维细胞凋亡的影响[J].陕西医学杂志,2016,(09):1110.
Shao Jingyun,Liu An,Du Xusheng,et al.[J].,2016,(7):1110.
[2]彭卓,李维,牛泽群,等.长链非编码RNAHOTAIR对非小细胞肺癌迁移与侵袭能力的影响[J].陕西医学杂志,2017,(06):692.
[3]张胜超,陈 浩,秦 宣,等.肺浸润性腺癌组织中去泛素化酶USP17与基质金属蛋白9 的表达研究*[J].陕西医学杂志,2019,(4):531.
ZHANG Shengchao,CHEN Hao,QIN Xuan,et al.Expression and significance of USP17 and MMP9 in lung invasive adenocarcinoma[J].,2019,(7):531.
[4]杨元利,张永峰△,窦权利.老年肺结核病130例临床分析[J].陕西医学杂志,2019,(12):1691.